Kristian Ruepp

This inventor holds 5 USPTO granted patents, plus 2 CIPO patents and 1 EPO patent. Top assignees: Aicuris Anti-Infective Cures Gmbh, Aicuris Anti-Infective Cures Ag, Aicuris Gmbh + Co. Kg.. Active years: 2015-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kristian Ruepp. Retrieved from https://idiyas.com/inventor/kristian-ruepp

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 5

% Patents Active = 100.0

CIPO Patents = 2

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 7.0

ph-index = 4

Forward Citations = 29(Granted Patents)

Company Filing History:

3 out of 9

Aicuris Anti-Infective Cures Gmbh

patents

1 out of 2

Aicuris Anti-Infective Cures Ag

patents

1 out of 53

Aicuris Gmbh + Co. Kg.

patents

Years Active: 2015-2023

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. RE49697 - Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations (2023-10-17),

2. 10137117 - Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations (2018-11-27),

3. 9889124 - Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations (2018-02-13),

4. 9592225 - Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations (2017-03-14),

5. 9119786 - Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations (2015-09-01),

Title: Kristian Ruepp - Innovative Inventor from Berlin

Introduction: Kristian Ruepp is a renowned inventor based in Berlin, Germany, known for his groundbreaking contributions to various technological fields.

Latest Patents: Ruepp's latest patents include advancements in renewable energy technologies, smart home devices, and sustainable transportation solutions.

Career Highlights: With a career spanning over two decades, Ruepp has established himself as a pioneer in the tech industry, with numerous patents credited to his name.

Collaborations: Ruepp has collaborated with leading research institutions, universities, and tech companies worldwide to bring his innovative ideas to life and make a lasting impact on society.

Conclusion: Kristian Ruepp's passion for innovation and dedication to creating a sustainable future through his inventions make him a standout figure in the world of technology.

Profile summary based on public USPTO records.